These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17474988)

  • 1. Nectin-4 is a new histological and serological tumor associated marker for breast cancer.
    Fabre-Lafay S; Monville F; Garrido-Urbani S; Berruyer-Pouyet C; Ginestier C; Reymond N; Finetti P; Sauvan R; Adélaïde J; Geneix J; Lecocq E; Popovici C; Dubreuil P; Viens P; Gonçalves A; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Lopez M
    BMC Cancer; 2007 May; 7():73. PubMed ID: 17474988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17.
    Fabre-Lafay S; Garrido-Urbani S; Reymond N; Gonçalves A; Dubreuil P; Lopez M
    J Biol Chem; 2005 May; 280(20):19543-50. PubMed ID: 15784625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer.
    M-Rabet M; Cabaud O; Josselin E; Finetti P; Castellano R; Farina A; Agavnian-Couquiaud E; Saviane G; Collette Y; Viens P; Gonçalves A; Ginestier C; Charafe-Jauffret E; Birnbaum D; Olive D; Bertucci F; Lopez M
    Ann Oncol; 2017 Apr; 28(4):769-776. PubMed ID: 27998973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of Nectin-4 expression in luminal B (HER2 negative) breast cancer.
    Rajc J; Gugić D; Fröhlich I; Marjanović K; Dumenčić B
    Pathol Res Pract; 2017 Sep; 213(9):1102-1108. PubMed ID: 28778498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
    Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
    Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
    Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
    Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
    Shao Y; Sun X; He Y; Liu C; Liu H
    PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study.
    Li J; Liu L; Feng Z; Wang X; Huang Y; Dai H; Zhang L; Song F; Wang D; Zhang P; Ma B; Li H; Zheng H; Song F; Chen K
    Breast Cancer; 2020 Jul; 27(4):621-630. PubMed ID: 32040723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.
    Sethy C; Goutam K; Nayak D; Pradhan R; Molla S; Chatterjee S; Rout N; Wyatt MD; Narayan S; Kundu CN
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):245-259. PubMed ID: 31617074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
    Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
    World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer.
    Takano A; Ishikawa N; Nishino R; Masuda K; Yasui W; Inai K; Nishimura H; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Cancer Res; 2009 Aug; 69(16):6694-703. PubMed ID: 19679554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of the Nectin complex in human breast cancer and the role of Nectin-3 in the control of tight junctions during metastasis.
    Martin TA; Lane J; Harrison GM; Jiang WG
    PLoS One; 2013; 8(12):e82696. PubMed ID: 24386110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
    Samy N; Ragab HM; El Maksoud NA; Shaalan M
    Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies.
    Perrier A; Boelle PY; Chrétien Y; Gligorov J; Lotz JP; Brault D; Comperat E; Lefèvre G; Boissan M
    PLoS One; 2020; 15(1):e0227356. PubMed ID: 31910438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Potential of Nectin Expressions in Colorectal Cancer: An Exploratory Study.
    Kobecki J; Gajdzis P; Mazur G; Chabowski M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of Survivin and Nectin-4 expression in the prognosis of breast carcinoma.
    Athanassiadou AM; Patsouris E; Tsipis A; Gonidi M; Athanassiadou P
    Folia Histochem Cytobiol; 2011; 49(1):26-33. PubMed ID: 21526486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.